ONENESS BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159 TWD | +3.92% |
|
+6.71% | -18.25% |
ETFs positioned on Oneness Biotech Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 117 M€ | +1.54% | - | |
| 0.00% | 34 M€ | +2.43% | - | |
| 0.00% | 17 M€ | +1.44% | - | |
| 0.00% | 8 M€ | -0.60% | - |
ONENESS BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include health supplies, health food and healthy food. The Company is also involved in the development of new drugs for the treatment of wound healing in chronic diabetic foot ulcers, as well as the development of new anticancer drugs. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
159
TWD
Average target price
262
TWD
Spread / Average Target
+64.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.25% | 2.13B | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
- Stock Market
- Equities
- 4743 Stock
- Funds and ETFs Oneness Biotech Co., Ltd.
